← board
CBDY
distress 4/10 · elevated risk$0.000%today-60% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.6 yrs
Shares 1y
0%
Price & events
-20.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
-20.0%
1M
-29.4%
3M
-20.0%
6M
-40.0%
1Y
-45.5%
2Y
-92.5%
5Y
-90.0%
All
Overview
- Market Cap
- $740.43K
- Enterprise Value
- $8.01M
- Volume
- 0
- 52 Week Range
- $0.00 – $0.00
- Total Shares
- 617.03M
- % Held by Insiders
- 10.06%
- % Held by Institutions
- 0.00%
- Beta
- 1.23
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 617,025,999 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.